Morris Capital Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $3M | Sell |
4,347
-56
| -1% | -$38.6K | 2.82% | 13 |
|
|
2022
Q2 | $2.6M | Buy |
4,403
+78
| +2% | +$46.1K | 2.32% | 22 |
|
|
2022
Q1 | $3.02M | Sell |
4,325
-94
| -2% | -$65.7K | 2.35% | 19 |
|
|
2021
Q4 | $2.79M | Sell |
4,419
-55
| -1% | -$34.7K | 2.05% | 21 |
|
|
2021
Q3 | $2.71M | Sell |
4,474
-124
| -3% | -$75.1K | 2.13% | 21 |
|
|
2021
Q2 | $2.57M | Buy |
4,598
+110
| +2% | +$61.4K | 1.94% | 24 |
|
|
2021
Q1 | $2.12M | Sell |
4,488
-116
| -3% | -$54.9K | 1.72% | 27 |
|
|
2020
Q4 | $2.22M | Sell |
4,604
-287
| -6% | -$139K | 1.83% | 25 |
|
|
2020
Q3 | $2.74M | Sell |
4,891
-251
| -5% | -$141K | 2.42% | 15 |
|
|
2020
Q2 | $3.21M | Sell |
5,142
-167
| -3% | -$104K | 2.89% | 12 |
|
|
2020
Q1 | $2.59M | Buy |
+5,309
| New | +$2.59M | 2.77% | 13 |
|